Articles dans des revues avec comité de lecture (179)
  1. 47. Serste, T., Cornillie, A., Njimi, H., Pavesi, M., Arroyo, V., Putignano, A., Weichselbaum, L., Deltenre, P., Degré, D., Trepo, E., Moreno, C., & Gustot, T. (2018). The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis. Journal of hepatology, 69(2), 318-324. doi:10.1016/j.jhep.2018.02.022
  2. 48. Puoti, M., Foster, G. R., Wang, S., Mutimer, D., Gane, E., Moreno, C., Chang, T. T., Lee, S. S., Marinho, R. T., Dufour, J. F., Pol, S., Hezode, C., Gordon, S. S., Strasser, S., Thuluvath, P. J., Zhang, Z., Lovell, S., Pilot-Matias, T., & Mensa, F. F. (2018). High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis. Journal of hepatology, 69(2), 293-300. doi:10.1016/j.jhep.2018.03.007
  3. 49. Trepo, E., Goossens, N., Fujiwara, N., Song, W.-M., Colaprico, A., Marot, A., Spahr, L., Demetter, P., Sempoux, C., Im, G. Y., Saldarriaga, J., Gustot, T., Devière, J., Thung, S. S., Minsart, C., Serste, T., Bontempi, G., Abdelrahman, K., Henrion, J., Degré, D., Lucidi, V., Rubbia-Brandt, L., Nair, V. D., Moreno, C., Deltenre, P., Hoshida, Y., & Franchimont, D. (2018). Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis. Gastroenterology, 154(4), 965-975. doi:10.1053/j.gastro.2017.10.048
  4. 50. Marot, A., Dubois, M., Trepo, E., Moreno, C., & Deltenre, P. (2018). Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis. PloS one, 13(1), e0190823. doi:10.1371/journal.pone.0190823
  5. 51. Zoulim, F., Verbinnen, T., Shukla, U., Jessner, W., Moreno, C., Lee, S. S., Buggisch, P., Horban, A., Lawitz, E., Corbett, C., Lenz, O., & Fevery, B. (2018). A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection. Virology journal, 15(1), 26. doi:10.1186/s12985-018-0936-4
  6. 52. Francque, S., Cassiman, D., Smets, F., Komuta, M., Driessen, A., Dirinck, E., Danse, E., Op de Beeck, B., van Craenenbroeck, E., Van Nieuwenhove, Y., Hubens, G., Lanthier, N., Geerts, A., Moreno, C., Verbeke, L., Reynaert, H., van Steenkiste, C., Vonghia, L., Kwanten, W. W., Weyler, J., & Trepo, E. (2018). The Belgian association for study of the liver guidance document on the management of adult and paediatric non-alcoholic fatty liver disease. Acta Gastro-Enterologica Belgica (English ed.), 81(1), 55-81.
  7. 53. Bourgeois, S., Hillewaert, V., Van Remoortere, P., Van De Logt, J., Ouwerkerk-Mahadevan, S., Horsmans, Y., Nevens, F., Van Vlierberghe, H., Moreno, C., Beumont, M., Vijgen, L., Van Eygen, V., & Luo, D. (2017). Pharmacokinetic interactions between simeprevir and ledipasvir in treatment-naive hepatitis C virus genotype 1-infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen. Antimicrobial agents and chemotherapy, 61(12), e01217. doi:10.1128/AAC.01217-17
  8. 54. Marot, A., Belaid, A., Orlent, H., Serste, T., Michielsen, P., Colle, I., Laleman, W., De Galocsy, C., Reynaert, H., D'Heygere, F., Moreno, C., Doerig, C., Henrion, J., & Deltenre, P. (2017). Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients. Clinics and Research in Hepatology and Gastroenterology, 41(6), 656-663. doi:10.1016/j.clinre.2017.05.003
  9. 55. Dharancy, S., Moreno, C., Conti, F., Dumortier, J., Di Martino, V., Radenne, S., De Ledinghen, V., D'Alteroche, L., Silvain, C., Besch, C., Perre, P., Coilly, A., Botta-Fridlund, D., Francoz, C., Habersetzer, F., Montialoux, H., Abergel, A., Debette-Gratien, M., Rohel, A., Rossignol, E., Samuel, D., Duclos-Vallée, J.-C., Fougerou-Leurent, C., Pageaux, G.-P., Duvoux, C., Kamar, N., Leroy, V., Tran, A., Houssel-Debry, P., & Canva, V. (2017). Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study. American Journal of Transplantation, 17(11), 2869-2878. doi:10.1111/ajt.14490
  10. 56. Gustot, T., Fernández, J. J., Szabo, G., Albillos, A., Louvet, A., Jalan, R., Moreau, R., & Moreno, C. (2017). Sepsis in alcohol-related liver disease. Journal of hepatology, 67(5), 1031-1050. doi:10.1016/j.jhep.2017.06.013
  11. 57. Bielen, R., De Galocsy, C., Janssens, F., Van Overbeke, L., van Steenkiste, C., D'Heygere, F., Cool, M. M., Wuyckens, K., Nevens, F., Robaeys, G., Moreno, C., Van Vlierberghe, H., Bourgeois, S., Mulkay, J.-P., Vanwolleghem, T., Verlinden, W., Brixco, C., & Decaestecker, J. (2017). The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience. Journal of viral hepatitis, 24(11), 976-981. doi:10.1111/jvh.12726
  12. 58. Gane, E., Moreno, C., Colombo, M., Yoshida, E. E., Nelson, D., Collins, C., Lei, Y., Kosloski, M., Mensa, F. F., Lawitz, E., Pugatch, D., Papatheodoridis, G., Bräu, N., Brown, A., Pol, S., Leroy, V., & Persico, M. (2017). Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. The New England journal of medicine, 377(15), 1448-1455. doi:10.1056/NEJMoa1704053
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>